{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:24:13Z","timestamp":1787498653118,"version":"build-2736575974"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":4,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-026-04869-7","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T03:44:50Z","timestamp":1779680690000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Impact of genetic polymorphisms in the interleukin-18 and interleukin-21 genes on the risk and clinical outcomes of multiple sclerosis"],"prefix":"10.1186","volume":"26","author":[{"given":"Noha M.","family":"Bakr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1753-5779","authenticated-orcid":false,"given":"Noha A.","family":"Hashim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Adel","family":"El-Eshmawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatim A.","family":"El-Baz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,25]]},"reference":[{"issue":"4","key":"4869_CR1","doi-asserted-by":"publisher","first-page":"474","DOI":"10.4103\/aian.AIAN_515_18","volume":"22","author":"H Jahanbani-Ardakani","year":"2019","unstructured":"Jahanbani-Ardakani H, Alsahebfosoul F, Etemadifar M, Abtahi SH. Interleukin 18 polymorphisms and its serum level in patients with multiple sclerosis. Ann Indian Acad Neurol. 2019;22(4):474\u20136.","journal-title":"Ann Indian Acad Neurol"},{"issue":"14","key":"4869_CR2","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1177\/1352458520970841","volume":"26","author":"C -Walton","year":"2020","unstructured":"Walton C, King R, Rechtman L, Kaye W, Leray E, Marrie RA, Robertson N, La Rocca N, Uitdehaag B, van der Mei I, Wallin M, Helme A, Angood Napier C, Rijke N, Baneke P. Rising prevalence of multiple sclerosis worldwide: insights from the atlas of MS, third edition. Mult Scler. 2020;26(14):1816\u201321.","journal-title":"Mult Scler"},{"key":"4869_CR3","doi-asserted-by":"crossref","unstructured":"Halperin ST, \u2018t Hart BA, Luchicchi A, Schenk GJ. The forgotten brother: the innate-like B1 cell in multiple sclerosis. Biomedicines. 2022;10(3):606.","DOI":"10.3390\/biomedicines10030606"},{"issue":"1657","key":"4869_CR4","first-page":"9","volume":"10","author":"M Kolahdouzan","year":"2019","unstructured":"Kolahdouzan M, Futhey NC, Kieran NW, Healy LM. Novel molecular leads for the prevention of damage and the promotion of repair in neuroimmunological disease. Front Immunol. 2019;10(1657):9.","journal-title":"Front Immunol"},{"issue":"1","key":"4869_CR5","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1186\/s12974-020-01944-9","volume":"17","author":"V Govindarajan","year":"2020","unstructured":"Govindarajan V, de Rivero Vaccari JP, Keane RW. Role of inflammasomes in multiple sclerosis and their potential as therapeutic targets. J Neuroinflamm. 2020;17(1):260.","journal-title":"J Neuroinflamm"},{"issue":"1","key":"4869_CR6","first-page":"81","volume":"77","author":"AA Ali","year":"2022","unstructured":"Ali AA, Abdulaali AT, Razzaq A-AW. Impact of IL-21 gene polymorphisms (rs2055979) and the levels of serum IL-21 on the risk of multiple sclerosis. Arch Razi Inst. 2022;77(1):81\u20136.","journal-title":"Arch Razi Inst"},{"issue":"3","key":"4869_CR7","doi-asserted-by":"publisher","first-page":"520","DOI":"10.2174\/1871530320666200505123443","volume":"21","author":"M -Asgharzadeh","year":"2021","unstructured":"Asgharzadeh M, Najafi-Ghalehlou N, Poor BM, Asgharzadeh V, Pourostadi M, Vegari A, Kafil HS, Fadaee M, Farhoudi M, Rashedi J. IFN-\u03b3 and TNF-\u03b1 gene polymorphisms in multiple sclerosis patients in Northwest Iran. Endocr Metab Immune Disord Drug Targets. 2021;21(3):520\u20135.","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"4869_CR8","doi-asserted-by":"publisher","first-page":"102654","DOI":"10.1016\/j.msard.2020.102654","volume":"47","author":"NM Bakr","year":"2021","unstructured":"Bakr NM, Hashim NA, El-Baz HAE, Khalaf EM, Elharoun AS. Polymorphisms in proinflammatory cytokines genes and susceptibility to multiple sclerosis. Mult Scler Relat Disord. 2021;47:102654.","journal-title":"Mult Scler Relat Disord"},{"issue":"1","key":"4869_CR9","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3390\/jcm11010037","volume":"11","author":"IS -Barac","year":"2021","unstructured":"Barac IS, Iancu M, V\u0103c\u0103ra\u0219 V, Cozma A, Negrean V, S\u00e2mpelean D, Mure\u0219anu DF, Procopciuc LM. Potential contribution of IL-27 and IL-23 gene polymorphisms to multiple sclerosis susceptibility: an association analysis at genotype and haplotype level. J Clin Med. 2021;11(1):37.","journal-title":"J Clin Med"},{"key":"4869_CR10","doi-asserted-by":"publisher","first-page":"14","DOI":"10.4103\/0972-124X.145798","volume":"19","author":"MN Chitrapriya","year":"2015","unstructured":"Chitrapriya MN, Rao SR, Lavu V. Interleukin-17 and interleukin-18 levels in different stages of inflammatory periodontal disease. J Indian Soc Periodontol. 2015;19:14\u20137.","journal-title":"J Indian Soc Periodontol"},{"key":"4869_CR11","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.cytogfr.2016.07.001","volume":"32","author":"NL Sanders","year":"2016","unstructured":"Sanders NL, Mishra A. Role of interleukin-18 in the pathophysiology of allergic diseases. Cytokine Growth Factor Rev. 2016;32:31\u20139.","journal-title":"Cytokine Growth Factor Rev"},{"key":"4869_CR12","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1093\/eurheartj\/ehx261","volume":"39","author":"H -Xiao","year":"2018","unstructured":"Xiao H, Li H, Wang JJ, Zhang JS, Shen J, An XB, et al. IL18 cleavage triggers cardiac inflammation and fibrosis upon (-adrenergic insult. Eur Heart J. 2018;39:60\u20139.","journal-title":"Eur Heart J"},{"key":"4869_CR13","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1097\/CM9.0000000000000140","volume":"132","author":"XL -Niu","year":"2019","unstructured":"Niu XL, Huang Y, Gao YL, Sun YZ, Han Y, Chen HD, Gao XH, Qi RQ. Interleukin-18 exacerbates skin inflammation and affects microabscesses and scale formation in a mouse model of imiquimod- induced psoriasis. Chin Med J. 2019;132:690\u20138.","journal-title":"Chin Med J"},{"key":"4869_CR14","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1161\/CIRCRESAHA.120.315937","volume":"126","author":"A -Abbate","year":"2020","unstructured":"Abbate A, Toldo S, Marchetti C, Kron J, Van Tassell BW, Dinarello CA. Interleukin-1 and the inflammasome as therapeutic targets in cardiovascular disease. Circ Res. 2020;126:1260\u201380.","journal-title":"Circ Res"},{"key":"4869_CR15","doi-asserted-by":"publisher","first-page":"919973","DOI":"10.3389\/fimmu.2022.919973","volume":"13","author":"SA -Ihim","year":"2022","unstructured":"Ihim SA, Abubakar SD, Zian Z, Sasaki T, Saffarioun M, Maleknia S, Azizi G. Interleukin-18 cytokine in immunity, inflammation, and autoimmunity: biological role in induction, regulation, and treatment. Front Immunol. 2022;13:919973.","journal-title":"Front Immunol"},{"key":"4869_CR16","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1742-2094-7-9","volume":"7","author":"S Alboni","year":"2010","unstructured":"Alboni S, Cervia D, Sugama S, Conti B. Interleukin 18 in the CNS. J Neuroinflammation. 2010;7:9.","journal-title":"J Neuroinflammation"},{"issue":"10","key":"4869_CR17","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1089\/jir.2012.0029","volume":"32","author":"T Kawayama","year":"2012","unstructured":"Kawayama T, Okamoto M, Imaoka H, et al. Interleukin-18 in pulmonary inflammatory diseases. J Interferon Cytokine Res. 2012;32(10):443\u20139.","journal-title":"J Interferon Cytokine Res"},{"issue":"1","key":"4869_CR18","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.4314\/ahs.v19i1.2","volume":"19","author":"L-B Zhen","year":"2019","unstructured":"Zhen L-B, Sun Y-P, Chen Y-Y, Yin L-S. IL-18 polymorphisms and tuberculosis susceptibility: a meta-analysis. Afr Health Sci. 2019;19(1):1311\u201320.","journal-title":"Afr Health Sci"},{"key":"4869_CR19","doi-asserted-by":"crossref","unstructured":"Bazgir A, Farazmandfar T, Salehi A, Manzari RS, Attar M, Shahbazi M. Association of interleukin-18 gene promoter polymorphisms with coronary artery disease in northern Iranian population. Meta Gene. 2018;16:1\u20134.","DOI":"10.1016\/j.mgene.2018.01.001"},{"issue":"4","key":"4869_CR20","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1177\/0961203319834677","volume":"28","author":"V -Umare","year":"2019","unstructured":"Umare V, Pradhan V, Nath S, Rajadhyaksha A, Ghosh K, Nadkarni AH. Impact of functional IL-18 polymorphisms on genetic predisposition and diverse clinical manifestations of the disease in Indian SLE patients. Lupus. 2019;28(4):545\u201354. https:\/\/doi.org\/10.1177\/0961203319834677.","journal-title":"Lupus"},{"issue":"2","key":"4869_CR21","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1080\/08916934.2019.1710831","volume":"53","author":"IIF -Gomes da Silva","year":"2020","unstructured":"Gomes da Silva IIF, Lima CAD, Monteiro MLA, Barboza DASP, Rushansky E, Mariano MHQA, Sandrin-Garcia P, de Souza PRE, Maia MMD. IL1\u03b2, IL18, NFKB1 and IFNG gene interactions are associated with severity of rheumatoid arthritis: A pilot study. Autoimmunity. 2020;53(2):95\u2013101.","journal-title":"Autoimmunity"},{"issue":"14\u201315","key":"4869_CR22","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/j.micinf.2010.08.008","volume":"12","author":"JS Yi","year":"2010","unstructured":"Yi JS, Cox MA, Zajac AJ. Interleukin-21: a multifunctional regulator of immunity to infections. Microbes Infect. 2010;12(14\u201315):1111\u20139.","journal-title":"Microbes Infect"},{"issue":"5","key":"4869_CR23","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/nrd4296","volume":"13","author":"R Spolski","year":"2014","unstructured":"Spolski R, Leonard WJ. Interleukin-21: a double-edged sword with therapeutic potential. Nat Rev Drug Discov. 2014;13(5):379\u201395.","journal-title":"Nat Rev Drug Discov"},{"issue":"6","key":"4869_CR24","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/j.1399-0039.2009.01382.x","volume":"74","author":"H S\u00f8ndergaard","year":"2009","unstructured":"S\u00f8ndergaard H, Skak K. IL-21: roles in immunopathology and cancer therapy. Tissue Antigens. 2009;74(6):467\u201379.","journal-title":"Tissue Antigens"},{"key":"4869_CR25","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3109\/08916934.2014.944262","volume":"48","author":"J -Liu","year":"2015","unstructured":"Liu J, Cen H, Ni J, Zhang M, Li P, Yang XK, Leng RX, Pan HF, Ye DQ. Association of IL-21 polymorphisms (rs907715, rs2221903) with susceptibility to multiple autoimmune diseases: a metaanalysis. Autoimmunity. 2015;48:108\u201316.","journal-title":"Autoimmunity"},{"issue":"1","key":"4869_CR26","first-page":"7","volume":"4","author":"T -Gharibi","year":"2015","unstructured":"Gharibi T, Kazemi T, Aliparasti MR, Farhoudi M, Almasi S, Dehghanzadeh R, Seyfizadeh N, Babaloo Z. Investigation of IL-21 gene polymorphisms (rs2221903, rs2055979) in cases with multiple sclerosis of Azerbaijan, Northwest Iran. Am J Clin Exp Immunol. 2015;4(1):7\u201314.","journal-title":"Am J Clin Exp Immunol"},{"issue":"3","key":"4869_CR27","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1177\/0961203319829821","volume":"28","author":"Y -Meng","year":"2019","unstructured":"Meng Y, Xu H, Zhang S, Zhang J, Wang L, Tang H, Wu Y. Genetic polymorphisms near IL-21 gene associated with Th17 cytokines confer risk for systemic lupus erythematosus in Chinese Han population. Lupus. 2019;28(3):406\u201313.","journal-title":"Lupus"},{"issue":"4","key":"4869_CR28","doi-asserted-by":"publisher","first-page":"878","DOI":"10.3390\/genes14040878","volume":"14","author":"NM Carre\u00f1o-Saavedra","year":"2023","unstructured":"Carre\u00f1o-Saavedra NM, Reyes-P\u00e9rez IV, Machado-Sulbaran AC, Mart\u00ednez-Bonilla GE, Ram\u00edrez-Due\u00f1as MG, Mu\u00f1oz-Valle JF, Olaya-Valdiviezo V, Garc\u00eda-Iglesias T, Mart\u00ednez-Garc\u00eda EA, S\u00e1nchez-Hern\u00e1ndez PE. IL-21 (rs2055979 and rs2221903)\/IL-21R (rs3093301) polymorphism and high levels of IL-21 are associated with rheumatoid arthritis in Mexican patients. Genes (Basel). 2023;14(4):878.","journal-title":"Genes (Basel)"},{"key":"4869_CR29","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1097\/WCO.0000000000000319","volume":"29","author":"PP Axisa","year":"2016","unstructured":"Axisa PP, Hafler DA. Multiple sclerosis: genetics, biomarkers, treatments. Curr Opin Neurol. 2016;29:345\u201353.","journal-title":"Curr Opin Neurol"},{"issue":"2","key":"4869_CR30","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson AJ, Banwell BL, Barkhof F. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17(2):162\u201373.","journal-title":"Lancet Neurol"},{"issue":"11","key":"4869_CR31","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1212\/WNL.33.11.1444","volume":"33","author":"JF Kurtzke","year":"1983","unstructured":"Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983;33(11):444\u201352.","journal-title":"Neurology"},{"key":"4869_CR32","first-page":"1144","volume":"64","author":"RHSR Roxburgh","year":"2005","unstructured":"Roxburgh RHSR, Seaman SR, Masterman T, et al. Multiple Scler Severity Score Neurol. 2005;64:1144\u201351.","journal-title":"Multiple Scler Severity Score Neurol"},{"key":"4869_CR33","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1017\/S0022215108003733","volume":"123","author":"V Aseif","year":"2009","unstructured":"Aseif V, Mojtahedi Z, Khademi B, et al. Head and neck squamous cell carcinoma (HNSCC) is not associated with interleukin-18 promoter gene polymorphisms, a case control study. J Laryngol Otol. 2009;123:444\u20138.","journal-title":"J Laryngol Otol"},{"key":"4869_CR34","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1177\/1352458518763094","volume":"24","author":"K G\u00f6bel","year":"2018","unstructured":"G\u00f6bel K, Ruck T, Meuth SG. Cytokine signaling in multiple sclerosis: lost in translation. Mult Scler J. 2018;24:432\u20139.","journal-title":"Mult Scler J"},{"key":"4869_CR35","doi-asserted-by":"publisher","first-page":"103834","DOI":"10.1016\/j.msard.2022.103834","volume":"63","author":"A -Tempest","year":"2022","unstructured":"Tempest A, Veettil SK, Maharajan MK, Earl JC, Ngorsuraches S, Chaiyakunapruk N. Genetic biomarkers in multiple sclerosis: an umbrella review of meta-analyses of observational studies. Mult Scler Relat Disord. 2022;63:103834.","journal-title":"Mult Scler Relat Disord"},{"issue":"3","key":"4869_CR36","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1007\/s11033-013-3013-5","volume":"41","author":"S Karakas Celik","year":"2014","unstructured":"Karakas Celik S, \u00d6z ZS, Dursun A, Unal A, Emre U, Cicek S, Keni FM. Interleukin 18 gene polymorphism is a risk factor for multiple sclerosis. Mol Biol Rep. 2014;41(3):1653\u20138.","journal-title":"Mol Biol Rep"},{"key":"4869_CR37","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.clineuro.2016.04.027","volume":"146","author":"G Orhan","year":"2016","unstructured":"Orhan G, Eruyar E, Mungan S\u00d6, Ak F, Karahalil B. The association of IL-18 gene promoter polymorphisms and the levels of serum IL-18 on the risk of multiple sclerosis. Clin Neurol Neurosurg. 2016;146:96\u2013101.","journal-title":"Clin Neurol Neurosurg"},{"key":"4869_CR38","doi-asserted-by":"publisher","unstructured":"Cheng D, Hao Y, Zhou W, Ma Y. The relationship between interlukin-18 polymorphisms and allergic diseases: a meta-analysis. Biomed Res Int.\u00a02014;2014(1):290687.\u00a0https:\/\/doi.org\/10.1155\/2014\/290687","DOI":"10.1155\/2014\/290687"},{"key":"4869_CR39","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/S0165-5728(00)00407-0","volume":"112","author":"V Giedraitis","year":"2001","unstructured":"Giedraitis V, He B, Huang WX, et al. Cloning and mutation analysis of the human IL-18 promoter: a possible role of polymorphisms in expression regulation. J Neuroimmunol. 2001;112:146\u201352.","journal-title":"J Neuroimmunol"},{"key":"4869_CR40","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1038\/ni1377","volume":"7","author":"I Gutcher","year":"2006","unstructured":"Gutcher I, Urich E, Wolter K, Prinz M, Becher B. Interleukin 18-independent engagement of interleukin 18 receptor alpha is required for autoimmune inflammation. Nat Immunol. 2006;7:946\u201353.","journal-title":"Nat Immunol"},{"key":"4869_CR41","doi-asserted-by":"publisher","first-page":"492","DOI":"10.3389\/fimmu.2015.00492","volume":"6","author":"G Arellano","year":"2015","unstructured":"Arellano G, Ottum PA, Reyes LI, Burgos PI, Naves R. Stage-specific role of interferon-gamma in experimental autoimmune encephalomyelitis and multiple sclerosis. Front immunol. 2015;6:492.","journal-title":"Front immunol"},{"issue":"1","key":"4869_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/jop.12142","volume":"44","author":"R Lu","year":"2015","unstructured":"Lu R, Zhang J, Sun W, Du G, Zhou G. Inflammation-related cytokines in oral lichen planus: an overview. J Oral Pathol Med. 2015;44(1):1\u201314.","journal-title":"J Oral Pathol Med"},{"key":"4869_CR43","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3389\/fneur.2018.00135","volume":"9","author":"RW Keane","year":"2018","unstructured":"Keane RW, Dietrich WD, de Rivero Vaccari JP. Inflammasome proteins as biomarkers of multiple sclerosis. Front Neurol. 2018;9:10.","journal-title":"Front Neurol"},{"key":"4869_CR44","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/j.1399-0039.2009.01298.x","volume":"74","author":"M -Fedetz","year":"2009","unstructured":"Fedetz M, Ndagire D, Fernandez O, Leyva L, Guerrero M, Arnal C, Lucas M, Izquierdo G, Delgado C, Alcina A. Multiple sclerosis association study with the TENR-IL2-IL21 region in a Spanish population. Tissue Antigens. 2009;74:244\u20137.","journal-title":"Tissue Antigens"},{"key":"4869_CR45","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/j.1399-0039.2011.01734.x","volume":"78","author":"M Lind\u00e9n","year":"2011","unstructured":"Lind\u00e9n M, Nohra R, Sundqvist E, Khademi M, Hillert J, Alfredsson L, Olsson T, Kockum I. No evidence of IL21 association with multiple sclerosis in a Swedish population. Tissue Antigens. 2011;78:271\u20134.","journal-title":"Tissue Antigens"},{"issue":"6","key":"4869_CR46","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1007\/s10753-012-9497-7","volume":"35","author":"L Ding","year":"2012","unstructured":"Ding L, Wang S, Chen GM, Leng RX, Pan HF, Ye DQ. A single nucleotide polymorphism of IL-21 gene is associated with systemic lupus erythematosus in a Chinese population. Inflammation. 2012;35(6):1781\u20135.","journal-title":"Inflammation"},{"issue":"11","key":"4869_CR47","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1089\/dna.2014.2559","volume":"33","author":"H Wang","year":"2014","unstructured":"Wang H, Wang M, Feng Z, et al. Functional interleukin-21 polymorphism is a protective factor of diffuse large B\u2010cell lymphoma. DNA Cell Biol. 2014;33(11):775\u201380.","journal-title":"DNA Cell Biol"},{"key":"4869_CR48","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/nrg3051","volume":"12","author":"ZE Sauna","year":"2011","unstructured":"Sauna ZE, Kimchi-Sarfaty C. Understanding the contribution of synonymous mutations to human disease. Nat Reviews Genet. 2011;12:683\u201391.","journal-title":"Nat Reviews Genet"},{"key":"4869_CR49","doi-asserted-by":"crossref","unstructured":"Carre\u00f1o-Saavedra NM, Reyes-P\u00e9rez IV, Machado-Sulbaran AC, Mart\u00ednez-Bonilla GE, Ram\u00edrez-Due\u00f1as MG, Mu\u00f1oz-Valle JF, Olaya-Valdiviezo V, Garc\u00eda-Iglesias T, Mart\u00ednez-Garc\u00eda EA, S\u00e1nchez-Hern\u00e1ndez PE. IL-21 (rs2055979 and rs2221903)\/IL-21R (rs3093301) polymorphism and high levels of IL-21 are associated with rheumatoid arthritis in Mexican patients. Genes. 2023;14(4):p. 878.","DOI":"10.3390\/genes14040878"},{"issue":"9","key":"4869_CR50","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/nri3871","volume":"15","author":"CA Dendrou","year":"2015","unstructured":"Dendrou CA, Fugger L, Friese MA. Immunopathology of multiple sclerosis. Nat Rev Immunol. 2015;15(9):545.","journal-title":"Nat Rev Immunol"},{"key":"4869_CR51","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.4049\/jimmunol.1601687","volume":"198","author":"JY Choi","year":"2017","unstructured":"Choi JY, Seth A, Kashgarian M, et al. Disruption of pathogenic cellular networks by IL-21 blockade leads to disease amelioration in murine lupus. J Immunol. 2017;198:2578\u201388.","journal-title":"J Immunol"},{"key":"4869_CR52","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s10067-017-3862-8","volume":"37","author":"R Xing","year":"2018","unstructured":"Xing R, Sun L, Wu D, Jin Y, Li C, Liu X, Zhao J. Autoantibodies against interleukin-21 correlate with disease activity in patients with rheumatoid arthritis. Clin Rheumatol. 2018;37:75\u201380.","journal-title":"Clin Rheumatol"},{"issue":"2","key":"4869_CR53","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.imbio.2015.09.021","volume":"221","author":"T Gharibi","year":"2016","unstructured":"Gharibi T, Majidi J, Kazemi T, Dehghanzadeh R, Motallebnezhad M, Babaloo Z. Biological effects of IL-21 on different immune cells and its role in autoimmune diseases. Immunobiology. 2016;221(2):357\u201367.","journal-title":"Immunobiology"},{"key":"4869_CR54","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1684\/ecn.2011.0287","volume":"22","author":"S Messaoudi","year":"2011","unstructured":"Messaoudi S, Al-Khateeb GM, Dendana M, Sater MS, Jazia KB, Nouira M, Almawi WY, Mahjoub T. Genetic variations in the interleukin-21 gene and the risk of recurrent idiopathic spontaneous miscarriage. Eur Cytokine Netw. 2011;22:123\u20136.","journal-title":"Eur Cytokine Netw"},{"key":"4869_CR55","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ajpath.2012.03.044","volume":"181","author":"MS Maddur","year":"2012","unstructured":"Maddur MS, Miossec P, Kaveri SV, Bayry J. Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies. Am J Pathol. 2012;181:8\u201318.","journal-title":"Am J Pathol"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-026-04869-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-04869-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-04869-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T17:02:26Z","timestamp":1780074146000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12883-026-04869-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,25]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4869"],"URL":"https:\/\/doi.org\/10.1186\/s12883-026-04869-7","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,25]]},"assertion":[{"value":"4 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical agreement was approved by the Institutional Review Board (IRB), Faculty of Medicine, Zagazig University, Egypt (ZU-IRB No. 9943), consistent with the rules of the Declaration of Helsinki. All recruited participants wrote their informed consent before their participation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"355"}}